The challenges of high-throughput sequencing
The rapid pace of development within the field of high-throughput sequencing, driven by frequent instrument updates, massive price drops on sequencing costs, new kits for specific applications coming out, new platforms emerging, and an exponential increase in data output year over year, makes this a challenging field to navigate.
Furthermore, today nobody knows what requirements and challenges we have to meet in six months or even two years.
Only a few years ago, selecting a bioinformatics platform was not an issue, as the amount of data and the types of analyses were easily handled by the local bioinformatics staff. However, the exponential growth in data-generation and the growing range of application-areas mean this is no longer the case.
Daily, we meet organizations struggling to keep their data analysis pipelines from breaking under the overwhelming amounts of data being generated and the constant flurry of updates.
Which analysis platform have you selected?
Unfortunately many organizations haven’t taken a step back to reflect on this and effectively don’t know which analysis platform to use now and in the future. Such a non-decision often means these organizations are driven into developing and continuously patching their own bioinformatics platform in an unstructured and resource-inefficient way.
In other words, it’s especially important to choose an analysis platform that will support your future requirements in terms of functionalities and scalability. A system that does not scale with the growing amounts of data – or is not continuously improved and expanded with the latest types of analyses, protocols and standards – is effectively a short term solution that ultimately has to be rebuilt after a few years.
Invest in your future
In order to minimize the total investment in hardware, software, and dedicated staff to do trivial non-scientific coding and integration work, we offer an enterprise platform specifically designed for high-throughput sequencing applications, guaranteed to meet your current as well as your future expectations and requirements.
How can we guarantee to support future concepts we currently don’t know anything about? Very simple. Our business model doesn’t rely on having to sell instruments and consumables, or rely on time-limited grants to develop one specific algorithm. At CLC bio we have one overall goal: To make the best possible user-friendly and optimized analysis software to analyze sequencing data. And if our customers aren’t successful when using our software, it’s likely we aren’t either. So in order to meet our goal, 90% of our revenue is re-invested in developing the software, ensuring the best chances of success for our customers.
By investing in our platform, your investment will secure support for your future research and create a flexible data analysis backbone that can scale as your volumes of data and research requirements potentially increase. Selecting CLC bio will ensure you the best return on investment and the lowest total cost of ownership.
Furthermore we’re well known for giving the world’s best and most dedicated customer support in this field, and our support is manned across the Globe from Tokyo, via Delhi, to Aarhus, and Boston, to name a few locations.
Everything we do is facilitated by our hardworking global team where more than 30% of the employees have a PhD and another 50% a MSc.
Flexible in every way
Although our own tools are world class, we acknowledge that third party commercial tools and open source tools often offer high value to our customers, which is why we have built an open analysis platform that easily integrates with external software. That ensures our users access to their preferred algorithms from a single user-friendly, graphical user-interface where the biologists can operate on all computer platforms, even though many of these tools are originally only supported on Linux.
If you have in-house resources with programming skills, it’s straightforward to use our freely available Application Programming Interface to integrate any algorithms, existing systems, or even your own specialized scripts. You can also get inspiration for such projects through our worldwide developer community which has more than one thousand external developers. Organizations that don’t have the time or internal resources can utilize CLC bio’s own experts in our consulting department, who have made and rolled out customized integrations and plug-ins for some of the biggest agro and life science organizations worldwide.
The power of being cross-platform
One of our key strategies is to be ‘cross-platform’, which is something we implement in all areas. That means we support all the major next generation sequencing platforms and of course also traditional Sanger-based sequencing. In terms of operating systems we support Mac OS X, Windows, and Linux. Furthermore, we support a wide variety of file systems and database management systems, such as Oracle, MySQL, and Microsoft SQL, among others. In summary, we want to give our users the power and flexibility to use and mix whatever platforms they like, without any constraints, enabling them to focus on their science and not on compatibility issues.
It’s all about being user-friendly
What is the value of developing the newest state-of-the-art algorithm, if only a few people in your organization know how to run the analysis? (And they’re busy updating the rest of the setup?)
Our software is made by biologists for biologists, as we believe in the value of putting user-friendly analysis capabilities in the hands of those who have the expert knowledge to interpret the results. And if they want to tweak the settings and run the analysis again, it’s only a few clicks right at their fingertips, rather than scheduling an appointment with the bioinformatics core (who are busy patching the analysis pipeline).
Did you know…
…that 2000 organizations around the globe have invested in CLC bio, including the world’s most prominent research institutions as well as the ten largest pharmaceutical companies?
Expect nothing but world class
The built-in tools of our platform are extremely optimized and always up-to-date with standards, protocols, and platforms. The speed of most of our algorithms have never been matched by other companies or open-source alternatives. It’s not because we cheat or use magic tricks.
The explanation is actually simple: Since 2005 we have dedicated a skilled team to focus on nothing else than to continuously improve our software. So we believe our customers have the right to expect world class performance. And that is exactly what we deliver, as demonstrated over and over in white-papers, academic publications, and third party benchmarks.
Free your experts to take your research further
General estimates say 80% of all global bioinformatics human resources are spent on everything but bioinformatics, like building user-interfaces, web-services, enterprise architectures and not least on keeping these infrastructures running and updated with the latest software versions.
In other words, the vast majority of the resources are spent on inventing and re-inventing the wheel.
If you put a platform in place that supports all of this, your bioinformatics experts can then focus on taking your exact research to the next level – where the scientific value lies.
Supporting the latest scientific developments
As the commercial marketleader within bioinformatics software and infrastructure, CLC bio receives input for future product developments directly from several thousands of scientists, many of them world class, within cancer research, plant and animal genomics, and molecular diagnostics.
Our future products and features will thus always reflect the latest scientific developments. We’re also part of multiple research grants, further emphasizing our commitment to being at the cutting edge within high-throughput sequencing.
Why not let the experts tailor you the perfect fit, rather than going for a standard factory-made model or stitching your own solution from scratch?
Download as PDF
Why Choose CLC bio?
How do you plan to solve your sequencing data analysis cHallenges tomorrow?Download